| AZN |
AstraZeneca
|
FTSE 100
| 2.30 |
£156.93B
| 10,402.00 | 2.79% |
| GSK |
GSK
|
FTSE 100
| 4.37 |
£56.85B
| 1,412.50 | 1.62% |
| HLN |
Haleon
|
FTSE 100
| 1.75 |
£33.64B
| 375.60 | 0.32% |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.48 |
£9.75B
| 1,119.00 | 0.54% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 1.62 |
£5.91B
| 272.00 | -5.69% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100
| 2.91 |
£4.41B
| 1,992.00 | 0.20% |
| HCM |
Hutchmed China
|
AIM
| |
£1.87B
| 227.00 | 4.80% |
| GNS |
Genus
|
FTSE 250
| 1.56 |
£1.35B
| 2,020.00 | -1.22% |
| INDV |
Indivior
|
FTSE 250
| |
£1.23B
| 1,084.00 | -3.10% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.02 |
£902.18M
| 227.00 | 1.34% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£853.81M
| 322.00 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.22 |
£463.76M
| 217.00 | 3.10% |
| AGY |
Allergy Therapeutics
|
AIM
| |
£347.95M
| 7.95 | -2.50% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap
| |
£335.89M
| 318.50 | 0.63% |
| PRTC |
Puretech Health
|
FTSE Small Cap
| |
£299.28M
| 126.00 | 1.12% |
| NIOX |
Niox Group
|
AIM
| 1.91 |
£283.94M
| 68.00 | |
| FARN |
Faron Pharmaceuticals OY
|
AIM
| |
£212.71M
| 202.50 | 1.10% |
| ANCR |
Animalcare Group
|
AIM
| 1.71 |
£202.83M
| 294.00 | -2.60% |
| TSTL |
Tristel
|
AIM
| 3.26 |
£198M
| 410.00 | 1.60% |
| BMK |
Benchmark Holdings
|
AIM
| |
£178.18M
| 24.20 | 1.50% |
| MXCT |
Maxcyte Inc
|
AIM
| |
£161.75M
| 147.69 | -1.20% |
| 4BB |
4basebio
|
AIM
| |
£152.45M
| 985.00 | -0.40% |
| BVXP |
Bioventix
|
AIM
| 5.64 |
£143.68M
| 2,750.00 | -2.20% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£120.81M
| 26.80 | 1.00% |
| AVCT |
Avacta Group
|
AIM
| |
£120.49M
| 31.00 | -7.00% |
| DXRX |
Diaceutics
|
AIM
| |
£100.17M
| 116.00 | -0.50% |
| SCLP |
Scancell Holdings
|
AIM
| |
£97.59M
| 9.50 | -1.10% |
| SDI |
SDI Group
|
AIM
| |
£93.05M
| 87.00 | -1.50% |
| ANP |
Anpario
|
AIM
| 2.71 |
£84.85M
| 420.00 | -0.90% |
| HVO |
Hvivo
|
AIM
| 1.72 |
£74.84M
| 11.00 | -5.10% |
| ANIC |
Agronomics
|
AIM
| |
£68.64M
| 7.05 | -0.60% |
| OBI |
Ondine Biomedical Inc
|
AIM
| |
£63.19M
| 14.25 | 2.60% |
| CREO |
Creo Medical Group
|
AIM
| |
£53.83M
| 13.25 | -0.80% |
| SPEC |
Inspecs Group
|
AIM
| |
£49.82M
| 50.00 | -0.30% |
| SBTX |
SkinBioTherapeutics
|
AIM
| |
£43.47M
| 16.80 | -14.90% |
| EAH |
Eco Animal Health Group
|
AIM
| |
£41.67M
| 60.06 | -4.30% |
| KMK |
Kromek Group
|
AIM
| |
£38.32M
| 5.84 | 8.70% |
| STX |
Shield Therapeutics
|
AIM
| |
£32.29M
| 3.10 | -7.90% |
| NCYT |
Novacyt SA
|
AIM
| |
£29.68M
| 42.15 | 4.20% |
| ABDX |
Abingdon Health
|
AIM
| |
£26.32M
| 7.00 | 2.60% |
| AGL |
Angle
|
AIM
| |
£24.11M
| 7.50 | -0.70% |
| FUM |
Futura Medical
|
AIM
| |
£23.09M
| 8.00 | 14.60% |
| POLB |
Poolbeg Pharma
|
AIM
| |
£23.01M
| 3.30 | -2.10% |
| TRX |
Tissue Regenix Group
|
AIM
| |
£21.01M
| 29.05 | -1.50% |
| SAR |
Sareum Holdings
|
AIM
| |
£20.83M
| 16.00 | -5.60% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£20.17M
| 22.50 | 0.60% |
| EDEN |
Eden Research
|
AIM
| |
£20M
| 3.75 | -2.40% |
| POLX |
Polarean Imaging
|
AIM
| |
£16.9M
| 1.40 | -3.20% |
| AREC |
Arecor Therapeutics
|
AIM
| |
£16.42M
| 43.50 | -1.30% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£13.4M
| 32.00 | -0.40% |
| IMM |
ImmuPharma
|
AIM
| |
£12.59M
| 2.30 | -3.00% |
| OPTI |
OptiBiotix Health
|
AIM
| |
£11.62M
| 12.00 | -3.30% |
| IXI |
Ixico
|
AIM
| |
£9.41M
| 10.15 | -1.50% |
| PRM |
Proteome Sciences
|
AIM
| |
£9M
| 3.05 | 8.00% |
| GDR |
Genedrive
|
AIM
| |
£8.9M
| 1.40 | -1.60% |
| CEL |
Celadon Pharmaceuticals
|
AIM
| |
£7.92M
| 13.40 | |
| RUA |
RUA Life Sciences
|
AIM
| |
£7.84M
| 12.25 | -6.90% |
| OBD |
Oxford BioDynamics
|
AIM
| |
£7.24M
| 0.32 | -4.00% |
| FAB |
Fusion Antibodies
|
AIM
| |
£7.16M
| 6.59 | 25.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£6.53M
| 0.70 | -2.30% |
| GENI |
Genincode
|
AIM
| |
£6.45M
| 2.25 | 1.40% |
| MHC |
MyHealthChecked
|
AIM
| |
£5.59M
| 10.75 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£2.91M
| 0.75 | -1.10% |
| VRCI |
Verici Dx
|
AIM
| |
£2.73M
| 1.12 | -4.80% |
| VAL |
ValiRx
|
AIM
| |
£2.15M
| 0.57 | -2.20% |
| PYC |
Physiomics
|
AIM
| |
£1.44M
| 0.46 | -3.80% |
| GUN |
Gunsynd
|
AIM
| |
£1.28M
| 0.13 | 9.50% |
| TRLS |
Trellus Health
|
AIM
| |
£1.05M
| 0.65 | 7.30% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |